ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,278Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 80

$624K Total Retail Price of All Prescriptions

Rank: 9 out of 80

545 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 545 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

4% of this provider’s 9,866 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 37%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $87 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 618 605 1 3
LOSARTAN POTASSIUM 485 471 2 1
METFORMIN HCL 395 360 3 8
FUROSEMIDE 356 335 4 10
LOVASTATIN 309 309 5 7
ATORVASTATIN CALCIUM 277 263 6 5
LISINOPRIL 241 230 7 4
GLYBURIDE 238 232 R 8 70
LEVOTHYROXINE SODIUM 221 195 9 6
LOSARTAN-HYDROCHLOROTHIAZIDE 218 218 10 22
ATENOLOL 202 179 11 29
ALENDRONATE SODIUM 183 183 12 12
ADVAIR DISKUS 174 151 13 72
ALLOPURINOL 168 158 14 14
HYDROCHLOROTHIAZIDE 165 158 15 16
NADOLOL 160 157 16 160
AZITHROMYCIN 158 144 17 56
CELEBREX 153 152 18 25
TRIAMTERENE-HCTZ 150 150 19 126
AMLODIPINE BESYLATE 141 136 20 2
TRAMADOL HCL 135 135 21 58
METOPROLOL SUCCINATE 135 111 21 11
PREDNISONE 133 128 23 15
DILTIAZEM 24HR ER 130 130 24 99
RANITIDINE HCL 127 126 25 40
POTASSIUM CHLORIDE 126 114 26 38
OMEPRAZOLE 120 114 27 9
COLCRYS 114 96 28 44
SYNTHROID 112 112 29 35
ZOLPIDEM TARTRATE 108 106 30 74
CLOPIDOGREL 105 105 31 36
GABAPENTIN 102 102 32 24
HYDROCODONE-ACETAMINOPHEN 97 94 S3 33 30
JANUVIA 85 83 34 23
METOPROLOL TARTRATE 80 80 35 20
PROMETHAZINE-CODEINE 75 72 R 36 140
GLIPIZIDE 74 74 37 55
FLUTICASONE PROPIONATE 73 70 38 82
SPIRONOLACTONE 73 73 38 142
PLAVIX 71 71 40 63
LIPITOR 68 63 41 67
CIPROFLOXACIN HCL 68 62 41 69
VENTOLIN HFA 67 59 43 123
DILTIAZEM ER 66 64 44 177
FINASTERIDE 66 66 44 119
VERAPAMIL ER 66 66 44 147
TRIAMCINOLONE ACETONIDE 64 62 47 62
DIOVAN 64 64 47 17
PANTOPRAZOLE SODIUM 63 51 49 45
DIGOXIN 56 56 50 48
HYDRALAZINE HCL 55 55 51 54
DEXAMETHASONE 51 48 52 287
EVISTA 50 50 53 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.